Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
28.05.25
/
50%
€15.95
Target price
28.05.26
€22.09
Performance (%)
66.77%
Price
16.04.26
€26.60
Summary
This prediction is currently active. With a performance of 66.77% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 28.05.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 0.377% | 0.377% |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $25.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€28.90
18.02.26
18.02.26
€35.46
18.02.27
18.02.27
-7.96%
16.04.26
16.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€27.00
29.01.26
29.01.26
€31.75
29.01.27
29.01.27
-1.48%
16.04.26
16.04.26